G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer

The vast majority of breast cancer death is a result of metastasis. Thus, accurate identification of patients who are likely to have metastasis is expected to improve survival. The G2M checkpoint plays a critical role in cell cycle. We hypothesized that breast cancer tumors with high activity of G2M...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshi, Masanori, Takahashi, Hideo, Tokumaru, Yoshihisa, Yan, Li, Rashid, Omar M., Matsuyama, Ryusei, Endo, Itaru, Takabe, Kazuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215898/
https://www.ncbi.nlm.nih.gov/pubmed/32331421
http://dx.doi.org/10.3390/ijms21082921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215898/
https://www.ncbi.nlm.nih.gov/pubmed/32331421
http://dx.doi.org/10.3390/ijms21082921

Ejemplares similares